Institute of Pharmacology and Toxicology, Tzu Chi University, Hualien, 970, Taiwan.
J Anal Toxicol. 2010 Mar;34(2):73-7. doi: 10.1093/jat/34.2.73.
Mephentermine and phentermine, substances prohibited in sports by the World Anti-Doping Agency, were found for the first time in urine specimens following the administration of a therapeutic medication, oxethazaine. In a recent sporting event, a urine specimen donor who tested positive for mephentermine and phentermine claimed consumption of Mucaine((R)) for treating stomach pain was the reason for testing positive. Five volunteers were administrated oxethazaine (a topical anesthetic found in the multi-ingredient medication Mucaine and its generic equivalent, Stoin, both of which are available in Taiwan), mephentermine, and phentermine. Excretion profiles of mephentermine and phentermine following the administration of these drugs were found to be similar. However, the mephentermine/phentermine ratios found in urine specimens collected at different time points following the administration of oxethazine and mephentermine were found to be characteristically different.
美芬丁胺和苯丁胺,世界反兴奋剂机构在运动中禁止的物质,首次在接受一种治疗药物,奥昔卡因后的尿液样本中被发现。在最近的一次体育赛事中,一名检测出美芬丁胺和苯丁胺阳性的尿液样本捐赠者声称,服用 Mucaine((R)) 治疗胃痛是导致检测呈阳性的原因。五名志愿者接受了奥昔卡因(一种多成分药物 Mucaine 中的局部麻醉剂,以及其通用等效药物 Stoin,两者均在台湾有售)、美芬丁胺和苯丁胺的治疗。在给予这些药物后,美芬丁胺和苯丁胺的排泄情况相似。然而,在给予奥昔卡因和美芬丁胺后不同时间点收集的尿液样本中发现的美芬丁胺/苯丁胺比值存在明显差异。